Información del producto
EC5026 is a drug that has been shown to have anti-inflammatory properties. It was found to suppress the production of pro-inflammatory cytokines such as IL-6 and TNF-α in wild-type mice in an oral dosage form. EC5026 also inhibits the production of inflammatory mediators such as prostaglandin E2, leukotriene B4, and epoxyeicosatrienoic acids. The drug has been shown to inhibit the expression of fatty acid amide hydrolase (FAAH) and monoacylglycerol lipase (MAGL). Inhibition of these enzymes leads to increased activation of cannabinoid receptors, which are involved in pain regulation.
EC5026 is not addictive and does not cause any changes in blood pressure or heart rate when administered orally at doses that have been shown to be effective for treatment of chronic inflammation.
Propiedades químicas
Consulta técnica sobre: 3D-JXC88532 EC5026
Si desea solicitar un presupuesto o realizar un pedido, por favor añada los productos deseados a su carrito y solicite un presupuesto o pedido desde el carrito. Es más rápido, más barato, y podrá beneficiarse de los descuentos y las ventajas disponibles.
